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Xenograft transplantation, first performed in the
early 20th century, has been used successfully in
traumatic wounds, burns, chronic ulcers, and surgical
defects. Xenografts should be considered when fac-
ing not only limited donor skin or multiple patient
comorbidities that may preclude successful full thick-
ness skin grafting, but also unusually large surgical
defects. Xenografts are commonly used for enhanced
granulation in preparation for full-thickness skin graft
placement especially over avascular areas such as
cartilage or bone. Xenografts reduce the inherent
tension of a wound, initiate proper epithelialization,
reduce postoperative complications, and allow for
acceptable outcomes.1 Traditionally, porcine xeno-
grafts are split-thickness skin grafts harvested with a
dermatome under aseptic conditions. Newer xeno-
grafts, derived from other components besides
dermal material, can be used as a biologic dressing
to both facilitate and accelerate wound healing with
decreased scar contraction. The MatriStem xenograft
(ACell, Columbia, MD) is an extracellular matrix
derived from porcine urinary bladder. Porcine transi-
tional epithelium, currently the most widely used,
provides optimum results in full-thickness wound
remodeling because of its resemblance in histologic
structure to human skin.We report an unusually large,
surgically excised squamous cell carcinoma (SCC)
managed successfully with the MatriStem xenograft.
CASE REPORT
A 57-year-oldHispanicmanpresentedwith a 45-3
20-cm biopsy-proven SCC, extending from the right
pretibial area to the ankle. After excision of the tumorthe Department of Dermatology, Mount Sinai School of
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bert.Bacigalupi@gmail.com.with Mohs surgery, the final defect measured 900 cm2
(Fig 1). After 2 full-thickness abdominal skin grafts, the
remaining upper three-quarters of the defect was
dressed with 700 cm2 3-layered MatriStem Wound
Matrix fenestrated sheets and 100-mg MatriStem
MicroMatrix (ACell) particles (Fig 2). Two additional
one-layered MatriStem xenograft wound sheets were
placed on postoperative weeks 2 and 4 to the wound
after resorption of the previously placed grafts. Partial
granulation was noted at 1 week postoperatively and
full-thickness remodelingat 4weeks (Fig 3).Complete
postsurgical remodeling was seen at the 3-month
follow-up visit (Fig 4). The patient was prophylacti-
cally placed on a 7-day course of levofloxacin, 750mg
daily, on the day of surgery. No complications were
seen.Outcomesof healingwith the xenografts serving
as biologic dressings were equivalent to the full-
thickness skin grafts, which can serve as an internal
control for comparison within the same patient.
DISCUSSION
Biologic dressings, xenografts, and allografts, are
an integral part of modern wound care. Various case
reports have surfaced in the dermatology and recon-
structive surgery literature on the use of human
cadaveric allografts and other biologic dressings,
offering a useful alternative to granulation for post-
operative management of surgical wounds. Although
there is no approved indication in dermatology, the
use of porcine xenografts, porcine acellular dermal
matrix (ADM), or porcine extracellular matrix from
urinary epithelium for the management of postoper-
ative Mohs micrographic surgery wounds and other
nonhealing ulcers has been described in theJAAD Case Reports 2015;1:200-2.
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Fig 2. Intraoperative placement of theMatriStemxenograft.
Fig 3. Full-thickness remodeling of defect managed with
xenograft superior to the ongoing healing of full-thickness
skin graft at 4-week follow-up visit.
Fig 4. Complete wound healing seen at 3-month follow-
up.
Fig 1. Final 900 cm2 defect of squamous cell carcinoma
treated with Mohs micrographic surgery.
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repairs.2,3 Specifically, porcine urinary transitional
epithelium has a role in providing the standarddressing for partial-thickness defects and temporary
coverage for full-thickness defects. From our experi-
ence, porcine xenografts have proven reliable in full-
thickness wound remodeling as well.
TheMatriStem system is formulated as dry particles
or sheets of nonecross-linked, completely resorbable,
acellular matrix material, replete with naturally occur-
ring collagens, laminins, and glycosaminoglycans and
numerous growth factors.4,5 The extracellular surface
of MatriStem is hypothesized to contribute to epithe-
lial and progenitor cell attachment and proliferation,
while the laminapropria surfacemaybeconducive for
integration into the wound bed and host connective
tissues. No synthetic material has been able to pro-
mote wound healing as effectively and quickly or
constructively remodel site-specific tissues where
scarring would be expected. ADM has been found
to accelerate the regeneration of epithelial and stem
cells, thus, shortening the healing time of wounds. By
aiding in the remodeling of skin structure, it conse-
quently has the added benefit of controlling hyper-
trophic scar at inception.6 In addition, because of
MatriStem’s ability to maintain an intact epithelial
basement membrane, it provides further protection
by providing antimicrobial activity, thereby reducing
the potential for postoperative wound infections and
further retarding wound healing.7 It should be noted
that in cleanwounds, the porcine skinwill adhere and
can be left intact after an initial inspection after 2 to 3
days. Dirty wounds, particularly sites on the lower
JAAD CASE REPORTS
JULY 2015
202 Bacigalupi and Khorasaniextremities, require regular dressing change, prefer-
ably weekly in the initial stages.
From our experience, the porcine transitional
epithelium xenograft system functions as an efficient
dressing material in preparation for full-thickness
skin grafts and deep partial-thickness postoperative
wounds, allowing for adequate epithelialization
during the postoperative treatment course. At this
time, MatriStem is approved for the management of
partial- and full-thickness wounds including chronic
pressure ulcers, venous ulcers, diabetic ulcers,
tunneled/undermined wounds, traumatic wounds
including burns, and surgical wounds. We now
report that porcine xenografts should also be consid-
ered in unusually large surgical defects not amenable
to surgical repair. These xenografts allow more
rapid, safe, and effective healing than granulation
alone with fewer complications such as hypertrophic
scarring or postoperative infections.REFERENCES
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